Presentation TCT 2012

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Presenter: Ajay Kirtane

October 23, 2012

REGISTER for free or LOG IN to view this content

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

DES/BRS/DCB

Presentation

TCT 2012

Up Next

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

More slides +

Presentation TCT 2012

Practice Trends in the United States: Nonadherence to the Mitral Valve Guidelines

Presenter: James Gammie

October 23, 2012

Presentation CIT 2013

New Clinical Indications…TAVR in Moderate Risk Patients: Experiences and Studies

Presenter: Martin B. Leon

March 22, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.